🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 022307102
Business: Alumis Inc. is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases.
Company Contact
- CEO
- Martin Babler
- CFO
- John Schroer
- Headquarters
- 280 East Grand Avenue, South San Francisco, CA 94080
- Phone
- 650-231-6625
- Investor Relations
- info@alumis.com